Thompson Davis & Co., Inc. Invitae Corp Transaction History

Thompson Davis & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$14.7 - $28.67 $372,645 - $726,784	-25,350 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$7.54 - $18.31 $108,199 - $262,748	14,350 Added 130.45%	25,350 $424,000
Q2 2018 Aug 03, 2018	BUY	$4.87 - $8.42 $53,570 - $92,620	11,000 New	11,000 $81,000
Q4 2017 Feb 05, 2018	SELL	$7.86 - $9.99 $39,300 - $49,950	-5,000 Closed	0 $0
Q3 2017 Oct 30, 2017	BUY	$8.89 - $10.4 $44,450 - $52,000	5,000	5,000 $47,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.